MDT Volume Alert - MDT 69.29 Medtronic Inc $MDT Hit a high of 69.33 Currently 11:15 Last price 69.29 +0.58 +0.84% With a day low of 68.46 and a current volume of 1,882,957.
MDT Medtronic Inc Recent Headline News
Midday Glance: Medical Devices companies
AP - 28 mins ago
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 1 p.m.:
ZMH: 110.90 (+0.48), JNJ: 108.88 (+0.06), MDT: 68.81 (+0.10), BAX: 70.54 (-0.09)
Mid-Term Election Impacts On The Market Revisited
Bret Jensen - at Seeking Alpha - 2 hrs 54 mins ago
SPY: 203.87 (-0.11), QQQ: 102.04 (+0.08), MDT: 68.81 (+0.10), IEF: 104.64 (-0.10), DIA: 175.86 (-0.09), STJ: 65.54 (-0.16), IWM: 117.22 (-0.07), TLT: 118.60 (-0.05)
Medtronic (MDT) Breaks Through Resistance at $69.08
Comtex SmarTrend(R) - Tue Nov 11, 10:14AM CST
Shares of Medtronic (NYSE:MDT) opened today above their pivot of $68.38 and have already reached the first level of resistance at $69.08. Should the shares continue to rise, the resistance pivots of $69.44 and $70.50 will be of interest.
MDT: 68.81 (+0.10)
Early Glance: Medical Devices companies
AP - Tue Nov 11, 10:17AM CST
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 10 a.m.:
ZMH: 110.90 (+0.48), JNJ: 108.88 (+0.06), MDT: 68.81 (+0.10), BAX: 70.54 (-0.09)
Actavis Says 'Let's Make A Deal'
Bill Gunderson - Seeking Alpha - Tue Nov 11, 8:42AM CST
I wrote about generic and specialty drug company Actavis plc (NYSE: ACT ) a while back detailing the rumored love triangle between them, Allergan (NYSE: AGN ), Valeant Pharmaceuticals (NYSE: VRX ), and Salix Pharmaceuticals (NASDAQ: SLXP ). On...
DRTX: 23.99 (-0.13), AGN: 194.98 (-0.26), ACT: 243.33 (-2.40), VRX: 127.84 (-0.15), MDT: 68.81 (+0.10), SLXP: 98.03 (+4.16), SNY: 47.09 (+0.90)
Latin American Markets for Minimally Invasive Spinal Implants Executive Summary - Market is expected to reach $60.7 million by 2019
M2 - Tue Nov 11, 6:49AM CST
Research and Markets (http://www.researchandmarkets.com/research/9zcj5t/latin_american) has announced the addition of the "Latin American Markets for Minimally Invasive Spinal Implants (Executive Summary)" report to their offering. This executive summary relates to the report 'Latin American Markets for Minimally Invasive Spinal Implants'. The Latin American minimally invasive surgery spinal implant market is expected to reach $60.7 million by 2019, driven by growth in lateral fusion procedures and increasing access to health care services in the region. The Latin American minimally invasive surgery spinal implant market includes minimally invasive interbody fusion and minimally invasive pedicle screws. Growth is expected in both segments as a result of the physiological and surgical advantages of MIS procedures. MIS interbody fusion was the most rapidly growing segment in 2012, followed by MIS pedicle screws. This report pertains to a forecast period of 10 years (2009 - 2019) for Argentina, Brazil and Mexico. Report Contents - Competitor Analysis - Identified Strategic Opportunities - Market Overview by Segment & Country - Trend Analysis by Segment & Country - Market Drivers & Limiters - Mergers & Acquisitions - Customer Feedback and Market Monitoring Main Segments Included: - MIS Interbody Fusion Market - MIS Pedicle Screw Market - Emerging Technologies Sub-Segments Included - Minimally Invasive Posterior Lumbar Interbody Fusion - Minimally Invasive Transforaminal Lumbar Interbody Fusion - Lateral Lumbar Interbody Fusion - Direct Lateral Interbody Fusion (DLIF?) - eXtreme Lateral Interbody Fusion (XLIF?) - Guided Lateral Interbody Fusion (GLIF) - Other Lateral Interbody Devices and Systems - Retractor MIS Pedicle Screw Market - Percutaneous MIS Pedicle Screw Market - Spinous Process Fixation - Facet Fixation - Minimally Invasive Sacroiliac Joint Fusion Companies Mentioned - Aesculap - Alphatec Spine - DePuy Synthes - Globus - K2M - LDR - Medical - Medtronic - NuVasive - Orthofix - Stryker - Zimmer For more information visit http://www.researchandmarkets.com/research/9z...n_american
MDT: 68.81 (+0.10)
U.S. Market for Peripheral Vascular Devices and Accessories Executive Summary: By 2020, the U.S. market for peripheral vascular devices will be worth over $6 billion
M2 - Tue Nov 11, 6:43AM CST
Research and Markets (http://www.researchandmarkets.com/research/3rwwd3/u_s_market_for) has announced the addition of the "U.S. Market for Peripheral Vascular Devices and Accessories (Executive Summary)" report to their offering. The peripheral vascular device market includes stents, percutaneous transluminal angioplasty (PTA) balloon catheters, atherectomy devices, chronic total occlusion devices, stent grafts, surgical grafts, arteriovenous (AV) access thrombectomy devices, inferior vena cava filters, catheters, guidewires, introducer sheaths, vascular closure devices and transcatheter embolization devices. These devices can be used for treating either coronary arterial or peripheral arterial disease (PAD), but only those devices used for peripheral procedures are included in this report. Older individuals and those who are obese have a higher risk of developing PAD. As result of a general increase in peripheral procedures and the development of new lower-limb treatments, the market for products such as stents and stent grafts will grow rapidly in the U.S. over the forecast period. Peripheral artery disease (PAD) remains a significantly under treated condition in the U.S and PAD is the leading cause of leg amputation. These factors will continue to drive growth in the peripheral vascular device market. In particular, the peripheral stent market is projected to grow over the forecast period. However, intense competition has led to price erosion and market penetration has moderated this once high growth segment. The launch of new technologies, including drug-eluting stents, will generate marginal revenues and only one company has sought FDA approval. In contrast, significant investments and acquisitions have taken place in the efforts of bringing the first drug-eluting balloon to the market, with Medtronic and C. R. Bard in a tight race to gain approval. Scope - Competitor Analysis - Identified Strategic Opportunities - Market Overview by Segment - Trend Analysis by Segment - Market Drivers & Limiters - Mergers & Acquisitions - Customer Feedback and Market Monitoring Main Segments Included: - Peripheral Vascular Stent Market - PTA Balloon Catheter Market - Atherectomy Device Market - Chronic Total Occlusion (CTO) Device Market - Embolic Protection Device Market - Stent Graft Market - Surgical Graft Market - AV Access Thrombectomy Device Market - Inferior Vena Cava Filter Market - Diagnostic and Interventional Catheter Market - Diagnostic and Interventional Guidewire Market - Introducer Sheath Market - Vascular Closure Device Market - Transcatheter Embolization Device Market Companies Mentioned - ALN International Inc. - Abbott Laboratories - AccessClosure - AngioDynamics - AngioScore - Angiotech - Argon Medical - Arstasis - Artegraft - Asahi Intecc USA - Atrax - Atrium Medical - B. Braun - Boston Scientific - C. R. Bard - Cardiovascular Systems Inc - Cardiva CeloNova Biosciences - Cook Medical - Cordis - Covidien - Endologix - IDEV Technologies - LeMaitre Vascular - MEDRAD - Maquet - Marine Polymer Technologies - Medtronic - Morris Innovative - Penumbra - Pfizer For more information visit http://www.researchandmarkets.com/research/3r...market_for About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
BSX: 13.36 (-0.09), ABT: 44.26 (+0.17), MDT: 68.81 (+0.10), CSII: 30.26 (+0.24), LMAT: 7.15 (-0.01)
Final Glance: Medical Devices companies
AP - Mon Nov 10, 5:07PM CST
NEW YORK (AP) — Shares of some top medical devices companies were mixed at the close of trading:
ZMH: 110.90 (+0.48), JNJ: 108.88 (+0.06), MDT: 68.81 (+0.10), BAX: 70.54 (-0.09)
Medtronic reports November 18
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 3:47PM CST
MDT: 68.81 (+0.10)
Medtronic to Announce Financial Results for Its Second Quarter of Fiscal Year 2015
Thomson Reuters ONE - Mon Nov 10, 3:00PM CST
MINNEAPOLIS - Nov 10, 2014 - Medtronic, Inc. (NYSE: MDT) announced today it will report financial results for the second quarter of its fiscal year 2015 on Tuesday, November 18, 2014. A news release will be issued at approximately 6:15 a.m. Central Standard Time and will be available at http://newsroom.medtronic.com. The earnings news release will include summary financial information for Medtronic's second fiscal quarter which ended October 24, 2014.
MDT: 68.81 (+0.10)
DexCom G4 Platinum Software Gains FDA Nod, Shares Surge - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 1:54PM CST
Following the announcement, shares of DexCom, Inc. (DXCM) shot up nearly 14.12% to close at $50.93 in the last trading session.
ABT: 44.26 (+0.17), JNJ: 108.88 (+0.06), DXCM: 53.03 (-0.47), MDT: 68.81 (+0.10)
Medtronic launches MRI-compatible ICD system in Japan
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 9:49AM CST
BSX: 13.36 (-0.09), MDT: 68.81 (+0.10), STJ: 65.54 (-0.16)
Medtronic Announces Japanese Approval and Launch of Implantable Cardioverter-Defibrillator System to Allow for Full-Body MRI Scans
Thomson Reuters ONE - Mon Nov 10, 8:01AM CST
Evera MRI(TM) ICD System Combines Proven Treatment Performance, Increased Longevity
MDT: 68.81 (+0.10)
Could This Obamacare Tax Be Repealed?
Sean Williams, The Motley Fool - Motley Fool - Sun Nov 09, 7:18AM CST
Source: White House on Flickr. With the midterm elections now in the rear-view mirror, Americans can begin speculating about the policies that will come out of Washington over the next two years. Personally, I can't say I'm a huge fan of the...
ZMH: 110.90 (+0.48), BSX: 13.36 (-0.09), MDT: 68.81 (+0.10), NUVA: 43.21 (+0.74)
Medical Device Companies Were Election Day Winners
Todd Campbell, The Motley Fool - Motley Fool - Sat Nov 08, 11:00AM CST
Source: Library of Congress The shift in power in Washington may have big implications for medical device companies if legislation is rekindled to ditch the 2.3% medical device tax. That tax, enacted as part of Obamacare to help fund the cost of...
BIIB: 324.42 (-3.45), MDT: 68.81 (+0.10), AMGN: 162.51 (-0.58), SYK: 88.48 (+0.04)
Stocks that could benefit from a GOP-led Congress
By KEN SWEET - AP - Sat Nov 08, 8:07AM CST
NEW YORK (AP) — Lower taxes for medical device makers. Lighter regulations for coal. If the new Republican-led Congress manages to push through these policy changes it could lift stocks in the health and energy industries, market strategists say.
JNJ: 108.88 (+0.06), MDT: 68.81 (+0.10), ZION: 29.59 (-0.08)
The Zacks Analyst Blog Highlights: AbbVie, Shire, Medtronic, Unilife and Derma Sciences
PR Newswire - Fri Nov 07, 8:30AM CST
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the AbbVie Inc. (NYSE:ABBV-Free Report), Shire plc (Nasdaq:SHPG-Free Report), Medtronic Inc. (NYSE:MDT-Free Report), Unilife Corporation (Nasdaq:UNIS-Free Report) and Derma Sciences Inc. (Nasdaq
SCI-Free Report).
DSCI: 8.42 (-0.08), UNIS: 3.07 (-0.59), MDT: 68.81 (+0.10), SHPG: 202.08 (+1.10)
MDT Medtronic Inc Recent Headline News
Midday Glance: Medical Devices companies
AP - 28 mins ago
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 1 p.m.:
ZMH: 110.90 (+0.48), JNJ: 108.88 (+0.06), MDT: 68.81 (+0.10), BAX: 70.54 (-0.09)
Mid-Term Election Impacts On The Market Revisited
Bret Jensen - at Seeking Alpha - 2 hrs 54 mins ago
SPY: 203.87 (-0.11), QQQ: 102.04 (+0.08), MDT: 68.81 (+0.10), IEF: 104.64 (-0.10), DIA: 175.86 (-0.09), STJ: 65.54 (-0.16), IWM: 117.22 (-0.07), TLT: 118.60 (-0.05)
Medtronic (MDT) Breaks Through Resistance at $69.08
Comtex SmarTrend(R) - Tue Nov 11, 10:14AM CST
Shares of Medtronic (NYSE:MDT) opened today above their pivot of $68.38 and have already reached the first level of resistance at $69.08. Should the shares continue to rise, the resistance pivots of $69.44 and $70.50 will be of interest.
MDT: 68.81 (+0.10)
Early Glance: Medical Devices companies
AP - Tue Nov 11, 10:17AM CST
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 10 a.m.:
ZMH: 110.90 (+0.48), JNJ: 108.88 (+0.06), MDT: 68.81 (+0.10), BAX: 70.54 (-0.09)
Actavis Says 'Let's Make A Deal'
Bill Gunderson - Seeking Alpha - Tue Nov 11, 8:42AM CST
I wrote about generic and specialty drug company Actavis plc (NYSE: ACT ) a while back detailing the rumored love triangle between them, Allergan (NYSE: AGN ), Valeant Pharmaceuticals (NYSE: VRX ), and Salix Pharmaceuticals (NASDAQ: SLXP ). On...
DRTX: 23.99 (-0.13), AGN: 194.98 (-0.26), ACT: 243.33 (-2.40), VRX: 127.84 (-0.15), MDT: 68.81 (+0.10), SLXP: 98.03 (+4.16), SNY: 47.09 (+0.90)
Latin American Markets for Minimally Invasive Spinal Implants Executive Summary - Market is expected to reach $60.7 million by 2019
M2 - Tue Nov 11, 6:49AM CST
Research and Markets (http://www.researchandmarkets.com/research/9zcj5t/latin_american) has announced the addition of the "Latin American Markets for Minimally Invasive Spinal Implants (Executive Summary)" report to their offering. This executive summary relates to the report 'Latin American Markets for Minimally Invasive Spinal Implants'. The Latin American minimally invasive surgery spinal implant market is expected to reach $60.7 million by 2019, driven by growth in lateral fusion procedures and increasing access to health care services in the region. The Latin American minimally invasive surgery spinal implant market includes minimally invasive interbody fusion and minimally invasive pedicle screws. Growth is expected in both segments as a result of the physiological and surgical advantages of MIS procedures. MIS interbody fusion was the most rapidly growing segment in 2012, followed by MIS pedicle screws. This report pertains to a forecast period of 10 years (2009 - 2019) for Argentina, Brazil and Mexico. Report Contents - Competitor Analysis - Identified Strategic Opportunities - Market Overview by Segment & Country - Trend Analysis by Segment & Country - Market Drivers & Limiters - Mergers & Acquisitions - Customer Feedback and Market Monitoring Main Segments Included: - MIS Interbody Fusion Market - MIS Pedicle Screw Market - Emerging Technologies Sub-Segments Included - Minimally Invasive Posterior Lumbar Interbody Fusion - Minimally Invasive Transforaminal Lumbar Interbody Fusion - Lateral Lumbar Interbody Fusion - Direct Lateral Interbody Fusion (DLIF?) - eXtreme Lateral Interbody Fusion (XLIF?) - Guided Lateral Interbody Fusion (GLIF) - Other Lateral Interbody Devices and Systems - Retractor MIS Pedicle Screw Market - Percutaneous MIS Pedicle Screw Market - Spinous Process Fixation - Facet Fixation - Minimally Invasive Sacroiliac Joint Fusion Companies Mentioned - Aesculap - Alphatec Spine - DePuy Synthes - Globus - K2M - LDR - Medical - Medtronic - NuVasive - Orthofix - Stryker - Zimmer For more information visit http://www.researchandmarkets.com/research/9z...n_american
MDT: 68.81 (+0.10)
U.S. Market for Peripheral Vascular Devices and Accessories Executive Summary: By 2020, the U.S. market for peripheral vascular devices will be worth over $6 billion
M2 - Tue Nov 11, 6:43AM CST
Research and Markets (http://www.researchandmarkets.com/research/3rwwd3/u_s_market_for) has announced the addition of the "U.S. Market for Peripheral Vascular Devices and Accessories (Executive Summary)" report to their offering. The peripheral vascular device market includes stents, percutaneous transluminal angioplasty (PTA) balloon catheters, atherectomy devices, chronic total occlusion devices, stent grafts, surgical grafts, arteriovenous (AV) access thrombectomy devices, inferior vena cava filters, catheters, guidewires, introducer sheaths, vascular closure devices and transcatheter embolization devices. These devices can be used for treating either coronary arterial or peripheral arterial disease (PAD), but only those devices used for peripheral procedures are included in this report. Older individuals and those who are obese have a higher risk of developing PAD. As result of a general increase in peripheral procedures and the development of new lower-limb treatments, the market for products such as stents and stent grafts will grow rapidly in the U.S. over the forecast period. Peripheral artery disease (PAD) remains a significantly under treated condition in the U.S and PAD is the leading cause of leg amputation. These factors will continue to drive growth in the peripheral vascular device market. In particular, the peripheral stent market is projected to grow over the forecast period. However, intense competition has led to price erosion and market penetration has moderated this once high growth segment. The launch of new technologies, including drug-eluting stents, will generate marginal revenues and only one company has sought FDA approval. In contrast, significant investments and acquisitions have taken place in the efforts of bringing the first drug-eluting balloon to the market, with Medtronic and C. R. Bard in a tight race to gain approval. Scope - Competitor Analysis - Identified Strategic Opportunities - Market Overview by Segment - Trend Analysis by Segment - Market Drivers & Limiters - Mergers & Acquisitions - Customer Feedback and Market Monitoring Main Segments Included: - Peripheral Vascular Stent Market - PTA Balloon Catheter Market - Atherectomy Device Market - Chronic Total Occlusion (CTO) Device Market - Embolic Protection Device Market - Stent Graft Market - Surgical Graft Market - AV Access Thrombectomy Device Market - Inferior Vena Cava Filter Market - Diagnostic and Interventional Catheter Market - Diagnostic and Interventional Guidewire Market - Introducer Sheath Market - Vascular Closure Device Market - Transcatheter Embolization Device Market Companies Mentioned - ALN International Inc. - Abbott Laboratories - AccessClosure - AngioDynamics - AngioScore - Angiotech - Argon Medical - Arstasis - Artegraft - Asahi Intecc USA - Atrax - Atrium Medical - B. Braun - Boston Scientific - C. R. Bard - Cardiovascular Systems Inc - Cardiva CeloNova Biosciences - Cook Medical - Cordis - Covidien - Endologix - IDEV Technologies - LeMaitre Vascular - MEDRAD - Maquet - Marine Polymer Technologies - Medtronic - Morris Innovative - Penumbra - Pfizer For more information visit http://www.researchandmarkets.com/research/3r...market_for About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
BSX: 13.36 (-0.09), ABT: 44.26 (+0.17), MDT: 68.81 (+0.10), CSII: 30.26 (+0.24), LMAT: 7.15 (-0.01)
Final Glance: Medical Devices companies
AP - Mon Nov 10, 5:07PM CST
NEW YORK (AP) — Shares of some top medical devices companies were mixed at the close of trading:
ZMH: 110.90 (+0.48), JNJ: 108.88 (+0.06), MDT: 68.81 (+0.10), BAX: 70.54 (-0.09)
Medtronic reports November 18
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 3:47PM CST
MDT: 68.81 (+0.10)
Medtronic to Announce Financial Results for Its Second Quarter of Fiscal Year 2015
Thomson Reuters ONE - Mon Nov 10, 3:00PM CST
MINNEAPOLIS - Nov 10, 2014 - Medtronic, Inc. (NYSE: MDT) announced today it will report financial results for the second quarter of its fiscal year 2015 on Tuesday, November 18, 2014. A news release will be issued at approximately 6:15 a.m. Central Standard Time and will be available at http://newsroom.medtronic.com. The earnings news release will include summary financial information for Medtronic's second fiscal quarter which ended October 24, 2014.
MDT: 68.81 (+0.10)
DexCom G4 Platinum Software Gains FDA Nod, Shares Surge - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 1:54PM CST
Following the announcement, shares of DexCom, Inc. (DXCM) shot up nearly 14.12% to close at $50.93 in the last trading session.
ABT: 44.26 (+0.17), JNJ: 108.88 (+0.06), DXCM: 53.03 (-0.47), MDT: 68.81 (+0.10)
Medtronic launches MRI-compatible ICD system in Japan
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 9:49AM CST
BSX: 13.36 (-0.09), MDT: 68.81 (+0.10), STJ: 65.54 (-0.16)
Medtronic Announces Japanese Approval and Launch of Implantable Cardioverter-Defibrillator System to Allow for Full-Body MRI Scans
Thomson Reuters ONE - Mon Nov 10, 8:01AM CST
Evera MRI(TM) ICD System Combines Proven Treatment Performance, Increased Longevity
MDT: 68.81 (+0.10)
Could This Obamacare Tax Be Repealed?
Sean Williams, The Motley Fool - Motley Fool - Sun Nov 09, 7:18AM CST
Source: White House on Flickr. With the midterm elections now in the rear-view mirror, Americans can begin speculating about the policies that will come out of Washington over the next two years. Personally, I can't say I'm a huge fan of the...
ZMH: 110.90 (+0.48), BSX: 13.36 (-0.09), MDT: 68.81 (+0.10), NUVA: 43.21 (+0.74)
Medical Device Companies Were Election Day Winners
Todd Campbell, The Motley Fool - Motley Fool - Sat Nov 08, 11:00AM CST
Source: Library of Congress The shift in power in Washington may have big implications for medical device companies if legislation is rekindled to ditch the 2.3% medical device tax. That tax, enacted as part of Obamacare to help fund the cost of...
BIIB: 324.42 (-3.45), MDT: 68.81 (+0.10), AMGN: 162.51 (-0.58), SYK: 88.48 (+0.04)
Stocks that could benefit from a GOP-led Congress
By KEN SWEET - AP - Sat Nov 08, 8:07AM CST
NEW YORK (AP) — Lower taxes for medical device makers. Lighter regulations for coal. If the new Republican-led Congress manages to push through these policy changes it could lift stocks in the health and energy industries, market strategists say.
JNJ: 108.88 (+0.06), MDT: 68.81 (+0.10), ZION: 29.59 (-0.08)
The Zacks Analyst Blog Highlights: AbbVie, Shire, Medtronic, Unilife and Derma Sciences
PR Newswire - Fri Nov 07, 8:30AM CST
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the AbbVie Inc. (NYSE:ABBV-Free Report), Shire plc (Nasdaq:SHPG-Free Report), Medtronic Inc. (NYSE:MDT-Free Report), Unilife Corporation (Nasdaq:UNIS-Free Report) and Derma Sciences Inc. (Nasdaq
SCI-Free Report). DSCI: 8.42 (-0.08), UNIS: 3.07 (-0.59), MDT: 68.81 (+0.10), SHPG: 202.08 (+1.10)
